| abstract |
Phosphorus substituted group-containing quinoline-like compound of formula (I) are provided in the present invention. The preparation process and application of the compound, and pharmaceutical formulation comprising phosphorus substituted group-containing quinoline-like compound are also disclosed. The compounds are protein kinase inhibitor and can be used for treating protein kinase abnormal activity-associated diseases, such as neoplasm, etc. |